<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02264483</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-EPO-2013-152</org_study_id>
    <nct_id>NCT02264483</nct_id>
  </id_info>
  <brief_title>Low-dose CT for Diagnosis of Pneumonia in COPD Exacerbations and Comparison of the Inflammatory Profile.</brief_title>
  <official_title>Assessment of the Degree of Pneumonia Underdiagnosis in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations Using Chest Low-dose Computed Tomography (CT) and Comparison of Inflammatory Profile Between the Two Entities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sociedad Española de Neumología y Cirugía Torácica</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      * Hypothesis: There is an underdiagnosis of pneumonia in COPD (Chronic Obstructive Pulmonary&#xD;
      Disease) exacerbations which could be demonstrated by performing low-dose chest CT.&#xD;
      Differences in the inflammatory profile in sputum and blood in patients with and without&#xD;
      pneumonia can be seen.&#xD;
&#xD;
      * Objective: To assess the degree of underdiagnosis of pneumonia in COPD exacerbations, using&#xD;
      chest low-dose CT and to compare clinical and inflammatory differences in blood and sputum&#xD;
      between patients with and without pneumonia.&#xD;
&#xD;
      *Material and Methods: Prospective observational study including 75 patients with the&#xD;
      diagnosis of COPD at the time of an exacerbation and with criteria for a respiratory tract&#xD;
      infection. At the time of inclusion clinical features, blood and sputum analysis, chest X-ray&#xD;
      and chest low-dose CT are performed. The investigators divide the patients into two groups&#xD;
      according to the existence of pneumonia and the inflammatory pattern in blood (inflammatory&#xD;
      markers) and sputum (cell populations and inflammatory markers) is compared between the two&#xD;
      branches.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with an exacerbation of their disease who have a Pneumonia diagnosed by low dose - CT (not detected by chest X-Ray).</measure>
    <time_frame>1 year and a half</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>COPD Exacerbation</condition>
  <arm_group>
    <arm_group_label>COPD exacerbation</arm_group_label>
    <description>No intervention.&#xD;
The subjects will be divided in 2 subgroups according to the image study:&#xD;
COPD exacerbation with pneumonia&#xD;
COPD exacerbation without pneumonia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD stable patients</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples and sputum (supernatant)&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        COPD patients with an exacerbation of their disease and symptoms of respiratory infection,&#xD;
        wich come to visit at outpatient pneumologic clinic.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        INCLUSION CRITERIA&#xD;
&#xD;
          -  clinical and spirometric diagnosis of COPD.&#xD;
&#xD;
          -  for study group: clinical symptoms of exacerbation and infection of low airway.&#xD;
&#xD;
          -  Signed informed consent.&#xD;
&#xD;
        EXCLUSION CRITERIA&#xD;
&#xD;
          -  No acceptance of informed consent.&#xD;
&#xD;
          -  The STUDY GROUP: treatment with antibiotic more tan 2 days before consultation.&#xD;
&#xD;
          -  Another entity known pulmonology other than COPD (non-obstructive disorders,&#xD;
             bronchiectasis, interstitial lung disease patients, severe pulmonary hypertension,&#xD;
             hypoventilation).&#xD;
&#xD;
          -  Chronic treatment with oral corticosteroids or immunosuppressive drug.&#xD;
&#xD;
          -  severe organ comorbidity such as cancer in advanced or terminal phase, pulmonary&#xD;
             tuberculosis with important involvement, severe pneumoconiosis.&#xD;
&#xD;
          -  Severe alteration of nutritional status.&#xD;
&#xD;
          -  Heart disease evolved.&#xD;
&#xD;
          -  Limitation for understanding the study (including psychiatric disorder, language&#xD;
             problem, social or cultural differences, etc.).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingrid Solanes, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Sebastian</last_name>
    <email>lsebastian@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian</last_name>
      <email>lsebastian@santpau.cat</email>
    </contact>
    <investigator>
      <last_name>Laura Sebastian, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomas Franquet, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana M Giménez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>September 12, 2014</study_first_submitted>
  <study_first_submitted_qc>October 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2014</study_first_posted>
  <last_update_submitted>August 28, 2015</last_update_submitted>
  <last_update_submitted_qc>August 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pneumonia in COPD exacerbation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

